Literature DB >> 28964466

Gadolinium Deposition and Chronic Toxicity.

Joana Ramalho1, Miguel Ramalho2.   

Abstract

Clinicians, radiologists, and patients should be aware of the most up-to-date data on the risks of gadolinium-based contrast agent (GBCA) administration. In this review, we discuss in vivo gadolinium retention, particularly brain tissue retention, and potential toxic effects. GBCA pharmacokinetics and biodistribution are reviewed briefly. Based on the more recent published literature and society guidelines, general safety recommendations for clinical practice are provided.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GBCAs; Gadolinium; Gadolinium deposition disease; Gadolinium retention; Gadolinium storage condition; MR imaging

Mesh：

Substances：

Year:  2017        PMID： 28964466     DOI： 10.1016/j.mric.2017.06.007

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN： 1064-9689            Impact factor:   2.266


  16 in total

Review 1.  The biological fate of gadolinium-based MRI contrast agents: a call to action for bioinorganic chemists.

Authors:  Mariane Le Fur; Peter Caravan
Journal:  Metallomics       Date:  2019-02-20       Impact factor: 4.526

Review 2.  Gadolinium-based contrast agents - review of recent literature on magnetic resonance imaging signal intensity changes and tissue deposits, with emphasis on pediatric patients.

Authors:  Einat Blumfield; David W Swenson; Ramesh S Iyer; A Luana Stanescu
Journal:  Pediatr Radiol       Date:  2019-03-29

Review 3.  MRI and multiple sclerosis--the evolving role of MRI in the diagnosis and management of MS: the radiologist's perspective.

Authors:  Alexis M Cahalane; Hugh Kearney; Yvonne M Purcell; Christopher McGuigan; Ronan P Killeen
Journal:  Ir J Med Sci       Date:  2017-11-25       Impact factor: 1.568

Review 4.  Round table: arguments in supporting abbreviated or biparametric MRI of the prostate protocol.

Authors:  Michele Scialpi; Eugenio Martorana; Pietro Scialpi; Alfredo D'Andrea; Riccardo Torre; Aldo Di Blasi; Stefano Signore
Journal:  Abdom Radiol (NY)       Date:  2020-12

Review 5.  State of the art in magnetic resonance imaging of hepatocellular carcinoma.

Authors:  Natally Horvat; Serena Monti; Brunna Clemente Oliveira; Camila Carlos Tavares Rocha; Romina Grazia Giancipoli; Lorenzo Mannelli
Journal:  Radiol Oncol       Date:  2018-11-26       Impact factor: 2.991

6.  Gadolinium Chloride Rescues Niemann⁻Pick Type C Liver Damage.

Authors:  Andrés D Klein; Juan Esteban Oyarzún; Cristian Cortez; Silvana Zanlungo
Journal:  Int J Mol Sci       Date:  2018-11-14       Impact factor: 5.923

Review 7.  Gadolinium Deposition in the Brain: Current Updates.

Authors:  Jin Woo Choi; Won-Jin Moon
Journal:  Korean J Radiol       Date:  2018-12-27       Impact factor: 3.500

Review 8.  Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives.

Authors:  Bang J Guo; Zhen L Yang; Long J Zhang
Journal:  Front Mol Neurosci       Date:  2018-09-20       Impact factor: 5.639

9.  Gadolinium-doped bioglass scaffolds promote osteogenic differentiation of hBMSC via the Akt/GSK3β pathway and facilitate bone repair in vivo.

Authors:  Dao-Yu Zhu; Bin Lu; Jun-Hui Yin; Qin-Fei Ke; He Xu; Chang-Qing Zhang; Ya-Ping Guo; You-Shui Gao
Journal:  Int J Nanomedicine       Date:  2019-02-11

10.  Effect of different doses of gadolinium contrast agent on clinical outcomes in MS.

Authors:  Nathalie Ackermans; Carolyn Taylor; Roger Tam; Robert Carruthers; Shannon Kolind; Heejun Kang; Mark S Freedman; David Kb Li; Anthony L Traboulsee
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.